2026-05-22T05:31:25Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/159782024-11-29T08:15:48Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19609col_20.500.12105_16968

00925njm 22002777a 4500 dc Martínez-Baz, Iván author Casado, Itziar author Miqueleiz, Ana author Navascués, Ana author Pozo Sanchez, Francisco author Trobajo-Sanmartín, Camino author Albéniz, Esther author Elía, Fernando author Burgui, Cristina author Fernández-Huerta, Miguel author Ezpeleta, Carmen author Castilla Catalán, Jesús author 2022-06 Compared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35% (95% CI: -3 to 45) for only previous seasons vaccination. Against influenza A(H3N2), estimates were 39% (95% CI: 16 to 55) and 24% (95% CI: -8 to 47) suggesting moderate effectiveness of current season vaccination and possible remaining effect of prior vaccinations. Euro Surveill. 2022 Jun;27(26):2200488. 10.2807/1560-7917.ES.2022.27.26.2200488 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 35775428 http://hdl.handle.net/20.500.12105/15978 Acute respiratory infection Case-control study Influenza Influenza vaccine Repeated vaccination Vaccine effectiveness Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22